Abstract
Abstract Preclinical Research The drug development process is witnessing a paradigm shift in which new therapies need to be tailored to well‐defined patient subgroups via companion diagnostic assays. This codevelopment paradigm is fostering a new set of partnerships between pharmaceutical and diagnostic developers. Although initial results have illustrated transformative effects associated with the codevelopment process, continued success in the development and commercialization of these paired products will require addressing the challenges and identifying strategies to guarantee future success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
